OnCore CTMS

Clinical Trial Management System

OnCore CTMS to be launched late 2021

The OnCore CTMS is a new system designed to enhance clinical trial infrastructure in Alberta, by increasing efficiencies in clinical trial management. The new system will enable increased capacity for additional studies, standardization and adoption of best practices, and improved study quality, budget management and regulatory compliance as a result of automated processes.

OnCore is a state-of-the-art enterprise solution that is used by leading research institutions in the US, including Yale University, Duke University, and the Dana-Farber/Harvard Cancer Centre.

The OnCore CTMS is a cloud-based solution, and will be hosted in a Canadian Data Centre.

The implementation project commenced in September 2020, and is expected to conclude by the end of 2021.

Quick Facts

Clinical Trials at UCalgary

  • Clinical trials are research studies involving human participants that include assignment to one or more interventions. Clinical trials are required to determine the safety and efficacy of interventions and are central to the approval process for medications, devices, and other interventions.
  • UCalgary is involved in a multitude of clinical trials, including industry-sponsored studies and investigator-initiated studies. Clinical trials provide advanced care options for patients, reduce healthcare cost and make a meaningful contribution to the scientific prestige of the University of Calgary.

OnCore CTMS

  • The University of Calgary led an initiative to enhance clinical trial infrastructure, partnering with the University of Alberta and Alberta Health Services to identify and implement a provincial Clinical Trial Management System (CTMS) for Alberta.
  • Alberta institutions are the first to bring OnCore to Canada.
  • OnCore was selected unanimously by all partners following an RFP process led by UCalgary in October 2019.
  • The implementation project is supported with funding from Alberta Innovates / AbSPORU.

 

 

Contact

oncoresupport@ucalgary.ca

UCalgary Project Team

Dr. Derek Exner, Executive Project Sponsor

Sabine Moritz, Implementation Lead

Mari Boesen, OnCore Coordinator and Trainer

Debby Scribner, Provincial Project Manager

Subscribe

CTMS project updates are sent to the Academic Staff list. If you are not an academic staff member, or if you wish to receive all CTMS project updates, please opt-in below.

Thanks! You'll get a confirmation email shortly.

Benefits of OnCore CTMS

Benefits for Researchers and Clinicians:

  • Streamlined clinical trial processes and an increase in operational efficiency through automation, reducing the burden of administrative tasks
  • Faster trial activation
  • Improved quality of data through a reduction in redundant data entry and the use of system data input validation techniques
  • Ability to manage increasingly complex protocol schedules
  • Protocol amendments, contract amendments, and other documentation will be easier to access as a result of the centralized repository for study information
  • Reduced workload for budget creation with access to a budget template using approved / standard pricelists
  • Improved study team communications and access to study information
  • Improved scheduling and notification of schedule changes for patients leading to an improved patient experience that may also result in a decrease in missed visits
  • Increased revenue as a result of improved budgeting and financial management, leading to an increase in cost-recovery and a decrease in missed invoice items
  • Ability to accrue and track real-time revenue and internal cost accruals through recording patient visits

Visit the project website for more a complete overview of business benefits. CAS login required. 

Benefits for Alberta:

  • A province-wide CTMS will help make Alberta more competitive on national and international stages. It will enable our researchers to attract more clinical trial opportunities.
  • Increased clinical trial opportunities will help to attract more world-class researchers and clinicians to Alberta.